| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
BCLI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.00M | - | - | |
| Other | 900.0K | - | - | |
| Dir | 343.8K | - | - | |
| Dir | 225.0K | $157.5K | - | |
| Dir | 225.0K | $157.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2015 | Bibring Yoram | Chief Financial Officer | Buy | 8,500 | $3.04 | $25,840.00 | +20.5% | |
| Aug 17, 2015 | Bibring Yoram | Chief Financial Officer | Buy | 41,500 | $2.92 | $121,180.00 | New |